secwatch.observer — SEC 8-K summary
======================================

Issuer:     RxSight, Inc. (RXST)
CIK:        0001111485
Form:       8-K/A
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001193125-26-115965
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

RxSight discloses CFO's sign-on bonus of $169K and corrects option vesting schedule
--------------------------------------------------------------------------------

- CFO Mark Wilterding's sign-on bonus determined at $169,348.10 and paid March 13, 2026.
- Sign-on bonus paid less payroll deductions and required withholding, per employment letter.
- Option vesting corrected: 25% vests on Jan 11, 2027 anniversary, balance monthly over next 3 years.
- Option fully vested after 4 years from Jan 11, 2026, subject to continued employment.
- Amendment filed to prior 8-K dated Jan 12, 2026 regarding CFO appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1111485/000119312526115965/0001193125-26-115965-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1111485/000119312526115965/d115727d8ka.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-115965

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer